(Total Views: 341)
Posted On: 02/15/2018 12:01:10 PM
Post# of 72440
Pfizer and Merck are having pipeline problems. Their clinical trials keep failing.
https://endpts.com/pfizer-merck-kgaa-say-thei...er%20field
Maybe they should make a deal for a novel new class of antibiotics. Or a p53 activator against cancer. Or a novel psoriasis drug.
https://endpts.com/pfizer-merck-kgaa-say-thei...er%20field
Maybe they should make a deal for a novel new class of antibiotics. Or a p53 activator against cancer. Or a novel psoriasis drug.
(3)
(0)Scroll down for more posts ▼
